A conditionally replicative, Wnt/beta-catenin pathway-based adenovirus therapy for anaplastic thyroid cancer (Q64377311)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218945 AND SRC:MED&resulttype=core&format=json

24 December 2019

title

A conditionally replicative, Wnt/beta-catenin pathway-based adenovirus therapy for anaplastic thyroid cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218945 AND SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

anaplastic thyroid cancer

1 reference

Abbosh PH

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218945 AND SRC:MED&resulttype=core&format=json

24 December 2019

Li X

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218945 AND SRC:MED&resulttype=core&format=json

24 December 2019

Li L

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218945 AND SRC:MED&resulttype=core&format=json

24 December 2019

Gardner TA

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218945 AND SRC:MED&resulttype=core&format=json

24 December 2019

Kao C

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218945 AND SRC:MED&resulttype=core&format=json

24 December 2019

Nephew KP

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218945 AND SRC:MED&resulttype=core&format=json

24 December 2019

language of work or name

English

0 references

publication date

12 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218945 AND SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218945 AND SRC:MED&resulttype=core&format=json

24 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218945 AND SRC:MED&resulttype=core&format=json

24 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218945 AND SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

399-408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218945 AND SRC:MED&resulttype=core&format=json

Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Anaplastic thyroid carcinoma: a 50-year experience at a single institution

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Anaplastic thyroid carcinoma: dismal outcome despite current treatment approach

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potency

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

beta-catenin signaling and cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Serum thyroglobulin as a risk factor for thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

More than one way to skin a catenin

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Stabilization of beta-catenin by genetic defects in melanoma cell lines

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Identification of c-MYC as a target of the APC pathway

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Smad4 and β-Catenin Co-activators Functionally Interact with Lymphoid-enhancing Factor to Regulate Graded Expression of Msx2

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers.

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Cytoplasmic control of cadherin-mediated cell-cell adhesion

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Virus-mediated oncolysis of thyroid cancer by a replication-selective adenovirus driven by a thyroglobulin promoter-enhancer region

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Treatment of 37 patients with anaplastic carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Adenovirus HSV-TK construct with thyroid-specific promoter: enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the camp pathway

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

ONYX-015, an E1B gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

ONYX-015 Enhances Radiation-Induced Death of Human Anaplastic Thyroid Carcinoma Cells

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Strategies to adapt adenoviral vectors for targeted delivery

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Transductional and transcriptional targeting of adenovirus for clinical applications

1 reference

https://api.crossref.org/works/10.1038/SJ.CGT.7701024

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7701024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17218945 AND SRC:MED&resulttype=core&format=json

24 December 2019

1 reference